Riding on the ‘clean label’ sports nutrition movement, beverage giant Coca-Cola announced that it is acquiring a minority stake in BodyArmor, structured to lead to a full acquisition.
From Clorox to Kirin to Johnson & Johnson, this year we’ve seen several consumer packaged goods (CPG) giants enter the dietary supplement space, either through acquisitions or major investments.
In its first foray into the supplement realm, Johnson & Johnson Consumer Inc. has acquired Zarbee’s, Inc., a manufacturer of dietary supplements and OTC remedies with Supplement Facts panels.
The founders of New Chapter have severed their relationship with Procter & Gamble because they said “financial pressures to accelerate profits” meant they could no longer in good conscience continue to associate themselves with the brand.
Global ingredients maker DuPont Nutrition & Health is divesting its alginates business to Germany-headquartered JRS Group, a specialist in functional additives and plant-based raw materials.
Since its acquisition of natural extract supplier Indfrag for $35 million last year, OmniActive Health Technologies is solidifying its presence in the US specialty botanicals and extracts market with a focus on healthy aging and healthy living.
CPG giant The Clorox Company has been growing its footprint in the dietary supplement space through acquisitions. During its recent earnings call, the company’s execs fielded questions concerning the logic behind its most recent purchase.
LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
Procter & Gamble will buy Merck KGaA’s consumer health unit for €3.4 billion euros – as the FMCG giant looks stem falling revenue by betting on vitamin ranges that have shown stable growth.
Supplement firm GNC looks set for considerable expansion in China, with Harbin Pharmaceutical Group Holding Co (Hayao) investing $300m to become the firm's largest single shareholder.
Chinese investment into Australian health firms, including supplement manufacturers, will continue to grow as the country's healthcare system matures and the population ages, analysts from KPMG are forecasting.
